GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp II (NAS:ARYBU) » Definitions » Total Inventories

ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Total Inventories : $0.00 Mil (As of Jun. 2020)


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition II Total Inventories?

ARYA Sciences Acquisition II's total inventories for the quarter that ended in Jun. 2020 was $0.00 Mil. ARYA Sciences Acquisition II's average total inventories from the quarter that ended in Mar. 2020 to the quarter that ended in Jun. 2020 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. ARYA Sciences Acquisition II's Net-Net Working Capital per share for the quarter that ended in Jun. 2020 was $N/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ARYA Sciences Acquisition II Total Inventories Historical Data

The historical data trend for ARYA Sciences Acquisition II's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARYA Sciences Acquisition II Total Inventories Chart

ARYA Sciences Acquisition II Annual Data
Trend
Total Inventories

ARYA Sciences Acquisition II Semi-Annual Data
Feb20 Mar20 Jun20
Total Inventories - - -

ARYA Sciences Acquisition II Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

ARYA Sciences Acquisition II  (NAS:ARYBU) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

ARYA Sciences Acquisition II's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2020 is

Net-Net Working Capital Per Share (Q: Jun. 2020 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.263+0.75 * 0+0.5 * 0-5.638
-0-0)/0
=N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ARYA Sciences Acquisition II's Days Inventory for the six months ended in Jun. 2020 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2020 )/Cost of Goods Sold (Q: Jun. 2020 )*Days in Period
=0/0*365 / 2
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

ARYA Sciences Acquisition II's Inventory Turnover for the quarter that ended in Jun. 2020 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2020 ) / Average Total Inventories (Q: Jun. 2020 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ARYA Sciences Acquisition II's Inventory to Revenue for the quarter that ended in Jun. 2020 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2020 ) / Revenue (Q: Jun. 2020 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

ARYA Sciences Acquisition II Total Inventories Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition II's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp II (NAS:ARYBU) » Definitions » Total Inventories
Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp II is a blank check company.
Executives
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc director 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Life Sciences Master Fund Ltd director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Adam Leo Stone director, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Ii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Jake Bauer director C/O MYOKARDIA, INC., 333 ALLERTON AVENUE, SOUTH SAN FRANCISCO CA 94080
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016
Chad M Robins director C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102